The big advantage of PSMA is it much smaller than an antibody so it doesn’t take so long to get into the tumour. This allows the PSMA constructs to be directly radio labelled.
- Forums
- ASX - By Stock
- CU6 - Media and Industry News
The big advantage of PSMA is it much smaller than an antibody so...
-
- There are more pages in this discussion • 235 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$6.29 |
Change
0.070(1.13%) |
Mkt cap ! $1.981B |
Open | High | Low | Value | Volume |
$6.29 | $6.30 | $6.25 | $1.396M | 222.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 2081 | $6.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.29 | 3502 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2530 | 6.280 |
14 | 4060 | 6.270 |
7 | 4028 | 6.260 |
5 | 2820 | 6.250 |
4 | 1887 | 6.240 |
Price($) | Vol. | No. |
---|---|---|
6.290 | 1644 | 8 |
6.300 | 5281 | 11 |
6.310 | 929 | 4 |
6.320 | 23790 | 4 |
6.330 | 20000 | 1 |
Last trade - 11.57am 15/08/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online